Loading…
Based on limited metadata, BioDiagnostic International received an FDA Warning Letter on July 12, 2018, regarding an unspecified product type classified as "Other." Without access to the full warning letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The issuing FDA office is also not identified in the provided metadata, limiting clarity on the exact regulatory scope and product category involved. To understand the complete regulatory concerns and required corrective actions, the full warning letter would need to be reviewed.